Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intraperitoneal chemotherapy for ovarian cancer: 2009 goals.

× No keyword cloud information.

6 in total

Review 1. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results.

Authors: Terence C Chua; Greg Robertson; Winston Liauw; Rhonda Farrell; Tristan D Yan; David L Morris
Journal: J Cancer Res Clin Oncol Date: 2009-08-23 Impact factor: 4.553

2. A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Authors: Natalie Gould; Michael W Sill; Robert S Mannel; P H Thaker; Paul Disilvestro; Steve Waggoner; S Diane Yamada; Deborah K Armstrong; Lari Wenzel; Helen Huang; Paula M Fracasso; Joan L Walker
Journal: Gynecol Oncol Date: 2011-12-11 Impact factor: 5.482

3. Practical considerations in ovarian cancer chemotherapy.

Authors: Mihaela Cristea; Ernest Han; Lennie Salmon; Robert J Morgan
Journal: Ther Adv Med Oncol Date: 2010-05 Impact factor: 8.168

4. Lessons learned from imaging mouse ovarian tumors: the route of probe injection makes a difference.

Authors: Myung Shin Han; Ching-Hsuan Tung
Journal: Quant Imaging Med Surg Date: 2014-06

5. A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Authors: Natalie Gould; Michael W Sill; Robert S Mannel; Premal H Thaker; Paul A DiSilvestro; Steven E Waggoner; S Diane Yamada; Deborah K Armstrong; Paula M Fracasso; Joan L Walker
Journal: Gynecol Oncol Date: 2012-08-31 Impact factor: 5.482

6. Clinical utility of targeted treatments in the management of epithelial ovarian cancer.

Authors: Cheryl Twu; Ernest S Han
Journal: Biologics Date: 2012-07-26

6 in total